Serologic Testing of Household Contacts of Confirmed Cases of COVID-19
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04393142|
Recruitment Status : Completed
First Posted : May 19, 2020
Last Update Posted : February 18, 2021
|Condition or disease|
|Study Type :||Observational [Patient Registry]|
|Actual Enrollment :||96 participants|
|Target Follow-Up Duration:||1 Day|
|Official Title:||Observational Trial Evaluating the Serologic Status of Household Contacts of Patients Diagnosed With COVID-19|
|Actual Study Start Date :||May 5, 2020|
|Actual Primary Completion Date :||February 16, 2021|
|Actual Study Completion Date :||February 16, 2021|
- Identify antibodies [ Time Frame: 1 day ]Identify the presence of IgM and IgG antibodies from intradomestic contacts of patients with Polymerase Chain Reaction for detected SARS-CoV-2 .
- Determine antibody sensitivity [ Time Frame: 1 day ]Determine the sensitivity of IgM and IgG antibody detection by ELISA in direct eastern contacts of patients with PCR for detected SARS-CoV-2.
- IgM determination [ Time Frame: 1 day ]Determine the presence of IgM antibodies by ELISA in direct eastern contacts of patients with detected SARS-CoV-2 PCR.
- IgG determination [ Time Frame: 1 day ]Determine the presence of IgG antibodies by ELISA in direct eastern contacts of patients with detected SARS-CoV-2 PCR.
Biospecimen Retention: Samples With DNA
Blood samples will be obtained by capillary puncture or venipuncture for rapid testing of antibodies against SARS-CoV-2 (IVD COVID-19 IgM/IgG test kit, Singclean).
Samples will be stored in the laboratory, and discarded at the discretion of the researcher.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04393142
|Hospital Universitario José E. Gonzalez|
|Monterrey, Nuevo Leon, Mexico, 64460|
|Principal Investigator:||Adrian Camacho-Ortiz, MD||Hospital Universitario "Dr. Jose Eleuterio Gonzalez, UANL|